Head of Investor Relations

Place in the Organization

uniQure is dedicated to bring innovative therapies or unmet medical needs to patients. In doing so each function in uniQure is directly or indirectly responsible for the lives of patients. This responsibility should be part of our day-to-day working life by (i) living up to high quality standards and (ii) by recognizing the sense of urgency in areas of high medical need.

There is a lot to be excited about here at uniQure. We have a 26 year legacy in developing AAV-delivered gene therapies; securing the first approved gene therapy in the western world, we had the first commercially licensed gene therapy manufacturing facility and we have developed the first gene silencing therapy for Huntington’s Disease to gain RMAT designation. 

We are focused on advancing four clinical programs, driving innovation for indications that can achieve clinical Proof of Concept and enabling technology investments focused on novel CNS capsids and next-generation cargo for AAV delivery.

Reporting to the Chief Executive Officer, the Head of Investor Relations will play a pivotal role in shaping and executing uniQure’s investor relations strategy with a focus on securing uniQure’s appropriate valuation and global market position as a leader in the gene therapy space. 

The Head of Investor Relations will establish and maintain relationships with investors, analysts and shareholders to drive awareness and understanding of uniQure’s strategic mission. They will be act as a key spokesperson for uniQure internally and externally.

Key result areas (major duties, accountabilities and responsibilities)  

• Lead the Investor Relations function to develop and implement comprehensive investor relations strategies, initiatives and programs
• Work in close collaboration with the CEO, CFO, CLO and other executive leaders 
• Serve as the primary corporate liaison for uniQure with investors, analysts and the broader financial community
• Develop and implement an effective narrative and strategy for quarterly and annual results, including the development of financial results press releases, conference call scripts, slide presentations, road show materials, key messages, Q&A, briefing materials and other related content to be used with both internal and external stakeholders including the financial community, patient advocacy communities and media
• Lead the preparation of investor materials including earnings calls, SEC filings, ESG, IR Board reports ensuring accuracy and compliance with regulatory requirements and corporate governance
• Establish a strategic targeting program to attract new investors and sell-side analysts, while maintaining relationships with existing key investors and analysts
• Remain informed, analyze and proactively respond to market trends, industry peer activities and shareholder feedback
• Provide insights and recommendations to the executive leadership team